filmov
tv
MDS/MPN/AML Session
Показать описание
Dr. Jeanne Palmer and Dr. Cecilia Arana Yi discuss MDS/MPN/ AML session and answer questions.
Mayo Clinic
Mayo Clinic
Health Care (Issue)
Healthcare Science (Field Of Study)
Рекомендации по теме
1:10:32
MDS/MPN/AML Session
0:05:48
MDS/MPN Overlap Syndromes and Myelofibrosis
0:08:11
Non Transplant Treatments for MDS & Secondary AML (Co-Chair Summary)
0:01:12
ABNL MARRO: ongoing clinical study investigating MDS/MPN overlap syndromes
0:10:30
MDS/MPN
0:01:26
Current and emerging prognostic factors for MDS/MPN
0:56:48
Molecular Genetics of MDS/MPN Overlap Syndromes
0:17:29
ICAHO20 ASCO Direct™ Highlights - Rapid-Fire Q&A MDS/MPN/AML - Dr. Anna Halpern
1:01:19
Living Well with MDS MPN Overlap
0:02:07
International ABNL-MARRO trial for MDS/MPN overlap syndromes
0:50:26
MDS - AML - 2020 Spring Virtual Conference: When MDS becomes AML - for High-Risk MDS Patients
0:01:31
PevAz update: pevonedistat & azacitidine in R/R MDS and MDS/MPN after DNMTi failure
0:31:17
ICAHO19 - Hematologic malignancies: MDS/MPN what is new?
1:13:29
Understanding Higher Risk MDS and Transtion to AML
0:12:26
MDS/MPN 2022 UPDATES
0:19:37
2021 West Oncology APP | Treatment Options for Elderly AML/MDS Patients
0:14:55
High-Risk Myelodysplastic Syndromes and Low-Blast Acute Myeloid Leukemia: Q&A
1:04:28
Understanding MDS and MPN Overlap Syndrome
1:00:43
MDS transformation to AML
0:27:35
Expert Perspectives: MPN and MDS
0:11:50
Apporach to Management of MDS/MPN - Dr. Damiano Rondelli, Part 1
1:36:58
Virtual Series Session 3: Myelodysplastic Syndromes and Acute Myeloid Leukemia
0:15:30
Treatments for MDS and Secondary AML, with Drs O. Odenike and D. Sallman
0:16:48
Molecular Characterization & Clonal Architecture of Adult MDS/MPN - L Palomo